OpenVSafe by OpenVAERS
Search V-safe

ZJS-30301-67683

2 vaccinations 7 coded responses 13 check-ins 7 free-text entries 2 call cases
Sex
Female
Age at first dose
56-60
ZIP prefix
958 / CA
Registered
2021-03-19
Relationship
Self
Race
Black or African American
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-03-19
    Registered in v-safe
  2. 2021-03-19
    Dose 1 — Pfizer-BioNTech
  3. 2021-03-19
    Health check-in — day 0, dose 1
    Feeling: Good · Site: Pain, Redness, Swelling · Headache, Fatigue or tiredness
    Adult check-in
  4. 2021-03-20
    Survey response — days 1–6 daily, dose 1
    MedDRA: No adverse event — Feeling: Good · Site: Pain · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities
    Free text: None
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  5. 2021-03-21
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Chills, Headache, Muscle or body aches, Fatigue or tiredness
    Adult check-in
  6. 2021-03-24
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Headache
    Adult check-in
  7. 2021-03-28
    Health check-in — day 7, dose 1
    Feeling: Good · Headache, Muscle or body aches
    Adult check-in
  8. 2021-04-02
    Survey response — day 14, dose 1
    MedDRA: Fatigue, Somnolence — Feeling: Fair
    Free text: More fatigue and wanting to sleep a lot more.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  9. 2021-04-09
    Dose 2 — Pfizer-BioNTech
  10. 2021-04-16
    Health check-in — day 7, dose 2
    Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness
    Adult check-in
  11. 2021-04-23
    Health check-in — day 14, dose 2
    Feeling: Fair
    Adult check-in
  12. 2021-04-30
    Survey response — day 21, dose 2
    MedDRA: Cough variant asthma — Feeling: Good
    Free text: Asthmatic cough has been happening a little more throughout the day/night.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  13. 2021-05-07
    Survey response — day 28, dose 2
    MedDRA: Systemic lupus erythematosus, Urinary tract infection — Feeling: Poor · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: Lupus aches, and UTI infection.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  14. 2021-05-07
    Report sent to call center — day 28, dose 2
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    1 call case(s)
  15. 2021-05-14
    Survey response — day 35, dose 2
    MedDRA: Hospitalisation, Office visit, Urinary tract infection — Feeling: Good · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visit
    Free text: Had UTI, went to urgent care for medication and treatment.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  16. 2021-05-14
    Report sent to call center — day 35, dose 2
    Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    1 call case(s)
  17. 2021-05-21
    Survey response — day 42, dose 2
    MedDRA: Depression, Pre-existing disease — Feeling: Fair · Be unable to do your normal daily activities
    Free text: My depression has been worse for the past two weeks.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  18. 2021-07-10
    Survey response — 3 months, dose 2
    MedDRA: Injection site bruising — Feeling: Fair
    Free text: I have a dark mark on my arm where I received my shot. Its approximately 2-21/2wide and about 1 3/4high. It doesnt hurt and its starting to get lighter.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  19. 2022-01-12

Vaccinations

DoseDateManufacturerCo-administered
12021-03-19Pfizer-BioNTech
22021-04-09Pfizer-BioNTech

Call center

ReportedOutcomeVAERS-related outcome
2021-05-07 Unsuccessful
2021-05-14 Unsuccessful

Free text

Release 6 — days 1–6 daily, dose 1

2021-03-20

Systemic reaction (other): None

Release 6 — day 14, dose 1

2021-04-02

Symptoms: More fatigue and wanting to sleep a lot more.

Release 8 — day 21, dose 2

2021-04-30

Symptoms: Asthmatic cough has been happening a little more throughout the day/night.

Release 8 — day 28, dose 2

2021-05-07

Symptoms: Lupus aches, and UTI infection.

Release 8 — day 35, dose 2

2021-05-14

Symptoms: Had UTI, went to urgent care for medication and treatment.

Release 8 — day 42, dose 2

2021-05-21

Symptoms: My depression has been worse for the past two weeks.

Release 9 — 3 months, dose 2

2021-07-10

Symptoms: I have a dark mark on my arm where I received my shot. Its approximately 2-21/2wide and about 1 3/4high. It doesnt hurt and its starting to get lighter.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDCough variant asthma ✓ ✓ ✓
SDDepression ✓ ✓ ✓
SDFatigue ✓ ✓ ✓
SDHospitalisation ✓ ✓ ○
SDInjection site bruising ✓ ✓ ✓
SDOffice visit · · ✓
SDPre-existing disease ✓ ✓ ✓
SDSomnolence ✓ ✓ ✓
SDSystemic lupus erythematosus ✓ ✓ ✓
SDUrinary tract infection ✓ ✓ ✓
SRONo adverse event ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release